Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,218) with videos related to
Page
of 122
Sort By:
Circulation Research
|
January 4, 2019
Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure
Joel L Berry, Wuqiang Zhu, Yao Liang Tang, et al.
Cancer Medicine
|
March 17, 2026
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience
Stefania Oliva, Marina Martello, Elona Saraci, et al.
Leukemia
|
July 4, 2018
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
The Canadian Journal of Cardiology
|
May 21, 2010
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk
Robert R Quinn, Brenda R Hemmelgarn, Raj S Padwal, et al.
Science Immunology
|
July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
Marie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Blood
|
June 10, 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Hematological Oncology
|
February 3, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, et al.
JACC. Cardiooncology
|
January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
Roberto Bolli, Emerson C Perin, James T Willerson, et al.
Page
of 122
Search research articles
Search
Showing results (1181-1190 of 1,218) with videos related to
Sort By:
Page
of 122
Circulation Research
|
January 4, 2019
Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure
Joel L Berry, Wuqiang Zhu, Yao Liang Tang, et al.
Cancer Medicine
|
March 17, 2026
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience
Stefania Oliva, Marina Martello, Elona Saraci, et al.
Leukemia
|
July 4, 2018
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
The Canadian Journal of Cardiology
|
May 21, 2010
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk
Robert R Quinn, Brenda R Hemmelgarn, Raj S Padwal, et al.
Science Immunology
|
July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
Marie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Blood
|
June 10, 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Hematological Oncology
|
February 3, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, et al.
JACC. Cardiooncology
|
January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
Roberto Bolli, Emerson C Perin, James T Willerson, et al.
Page
of 122